Nuance (NUAN +6.5%) rallies after stating it has no plans to make a bid for clinical...

|About: Nuance Communications, Inc. (NUAN)|By:, SA News Editor

Nuance (NUAN +6.5%) rallies after stating it has no plans to make a bid for clinical transcription rival M*Modal (MODL -1.6%), which is set to be purchased by JPMorgan's P-E arm for $14/share. The weak Q2 report delivered yesterday by M*Modal could be a reason why. M*Modal had previously disclosed it turned down a $17/share offer from a competitor widely believed to be Nuance, due to timing and antitrust worries.